Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Noxopharm Ltd.
DescriptionReformulation of idronoxil, a small molecule inhibitor of tumor-associated NADH oxidase (tNOX; ENOX2; APK1; COVA1)
Molecular Target Tumor-associated NADH oxidase (tNOX) (ENOX2) (APK1) (COVA1)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard Indication Cancer (unspecified)
Indication DetailsTreat chemotherapy-resistant cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today